Competing benefits of tumor necrosis factor-alpha for bacteria and for host defense.
Mizgerd
Joseph P
JP
D000818:Animals; D004926:Escherichia coli / Q000187:drug effects* / Q000254:growth & development; D016867:Immunocompromised Host / Q000187:drug effects / Q000276:immunology*; D066298:In Vitro Techniques; D051379:Mice; D009503:Neutropenia / Q000276:immunology; D018375:Neutrophil Activation / Q000187:drug effects / Q000276:immunology; D020556:Neutrophil Infiltration / Q000187:drug effects / Q000276:immunology; D018410:Pneumonia, Bacterial / Q000276:immunology* / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000254:growth & development; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology* / Q000494:pharmacology*
D014409:Tumor Necrosis Factor-alpha